Tag archive for ‘Five Prime Therapeutics’
Amgen acquisition of Five Prime Therapeutics
By businessnewstoday On Thursday, March 4th, 2021

Amgen to acquire Five Prime Therapeutics for gastric cancer candidate bemarituzumab

(adsbygoogle = window.adsbygoogle || []).push({}); Amgen acquisition of Five Prime Therapeutics : Amgen has agreed to acquire Five Prime Therapeutics, a clinical-stage biotech company, for about $1.9 More...

By pharmanewsdaily On Monday, October 1st, 2018

Five Prime, Zai Lab initiate phase 3 trial of bemarituzumab chemo combo

Five Prime Therapeutics and Zai Lab have dosed the first patient in a phase 3 study of bemarituzumab (FPA144) in combination with chemotherapy in patients having advanced gastric cancer (GC) or gastroesophageal More...